Halozyme Therapeutics Inc. Common Stock vs ON Semiconductor — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while ON Semiconductor trades at $77.5 (market cap $30.92B). The key difference: ON Semiconductor is far larger — about 2.5× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, ON Semiconductor nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and ON Semiconductor for 5 Days on average.
| HALO | ON | |
|---|---|---|
Market Cap | $12.58B | $30.92B |
Volume | 2,179,278 | 11,639,037 |
Sector | Health | Technology |
52-Week High | $115.22 | $133.93 |
52-Week Low | $61.63 | $44.90 |
Typical Hold Time | 1 Days | 5 Days |
Enterprise Value | $14.49B | $31.53B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.
Read more on ON →